Vancomycin-resistant
enterococcus (VRE) is a major nosocomial
pathogen
that exhibits enhanced infectivity due to its robust virulence and
biofilm-forming capabilities. In this study, 6-methoxyldihydrochelerythrine
chloride (6-MDC) inhibited the growth of exponential-phase VRE and
restored VRE’s sensitivity to vancomycin. 6-MDC predominantly
suppressed the de novo biosynthetic pathway of pyrimidine
and purine in VRE by the RNA-Seq analysis, resulting in obstructed
DNA synthesis, which subsequently weakened bacterial virulence and
impeded intracellular survival. Furthermore, 6-MDC inhibited biofilm
formation, eradicated established biofilms, reduced virulence, and
enhanced the host immune response to prevent intracellular survival
and replication of VRE. Finally, 6-MDC reduced the VRE load in peritoneal
fluid and cells significantly in a murine peritoneal infection model.
This paper provides insight into the potential antimicrobial target
of benzophenanthridine alkaloids for the first time.